CD8A and neoplasm: Strikingly, depletion of CD8+ T cells was not sufficient to abrogate response to ICB, while no tumor showed ICB-induced regression after depletion of CD4+ T cells (Fig. 3g, h; Supplementary Fig. 4e-f).